T. Rowe Price (TROW)
(Delayed Data from NSDQ)
$116.05 USD
+0.97 (0.84%)
Updated May 16, 2024 04:00 PM ET
After-Market: $116.12 +0.07 (0.06%) 7:58 PM ET
1-Strong Buy of 5 1
D Value D Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$116.05 USD
+0.97 (0.84%)
Updated May 16, 2024 04:00 PM ET
After-Market: $116.12 +0.07 (0.06%) 7:58 PM ET
1-Strong Buy of 5 1
D Value D Growth F Momentum D VGM
Zacks News
Invesco (IVZ) to Pay $1.2B to Buy Guggenheim's ETF Business
by Zacks Equity Research
Invesco (IVZ) has finally agreed to acquire the ETF business of Guggenheim Partners LLC for $1.2 billion in cash.
Ameriprise's Ratings Affirmed by A.M. Best, Outlook Stable
by Zacks Equity Research
A.M. Best affirms the ratings of Ameriprise Financial (AMP) and its subsidiaries. The outlook is stable.
5 Reasons Why T. Rowe Price (TROW) is Worth Buying Right Now
by Zacks Equity Research
T. Rowe Price Group (TROW) appears to be a promising buying opportunity, riding on organic growth, earnings strength and steady capital-deployment activities.
The Zacks Analyst Blog Highlights: Apple, Pfizer, Carnival, T. Rowe Price and Novo Nordisk
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Apple, Pfizer, Carnival, T. Rowe Price and Novo Nordisk
T. Rowe Price (TROW) Records Marginal Increase in August AUM
by Zacks Equity Research
T. Rowe Price (TROW) announced a slight rise in its AUM for August 2017.
Invesco's (IVZ) August AUM Increases on Source Acquisition
by Zacks Equity Research
Invesco's (IVZ) August 2017 AUM rises. The increase mainly reflects the AUM acquired with the completion of Source deal.
Top Analyst Reports for Apple, Pfizer & Carnival
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Apple (AAPL), Pfizer (PFE) and Carnival (CCL).
Why Is T. Rowe Price (TROW) Up 1.9% Since the Last Earnings Report?
by Zacks Equity Research
T. Rowe Price (TROW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
T. Rowe Price (TROW) Displays Revenue Rise: Time to Hold?
by Zacks Equity Research
T. Rowe Price's (TROW) forte lies in revenue growth, debt-free position and strong capital deployment activities. However, escalating expenses remain a key headwind.
5 Top-Performing T. Rowe Mutual Funds for the Second Half
by Zacks Equity Research
Steady inflows in its mutual funds and the ability to offer low cost mutual funds continuously make mutual funds from T. Rowe wise investment choices.
Snap Sinks To New Low, Then Soars: Here's Why
by Benjamin Rains
Shares of Snap (SNAP) fell to a new all-time intraday low again on Monday morning, only to see the company's stock price pop later.
T. Rowe Price Group (TROW) Records Improved AUM in July
by Zacks Equity Research
T. Rowe (TROW) reported a rise in assets under management sequentially as well as year over year.
4 Reasons to Add BNY Mellon (BK) Stock to Your Portfolio Now
by Zacks Equity Research
Underlying strength and solid growth prospects should drive BNY Mellon (BK) stock higher in the upcoming months.
Old National Outlook Downgraded by Moody's, Ratings Affirmed
by Zacks Equity Research
Moody's downgrade Old National Bancorp's (ONB) outlook to negative, following the company's acquisition announcement.
5 Reasons to Buy SEI Investments (SEIC) Stock Right Now
by Zacks Equity Research
SEI Investments (SEIC) stock is a solid pick now based on strong fundamentals and growth prospects.
Lazard (LAZ) Posts Impressive Q2 Earnings, Shares Down
by Zacks Equity Research
Lazard (LAZ) reported a positive surprise of 22.5% in second-quarter 2017. Strong top-line performance and growth in assets under management (AUM) were recorded.
Franklin (BEN) Posts In-Line Earnings in Q3, Costs Flare Up
by Zacks Equity Research
Franklin Resources' (BEN) third-quarter fiscal 2017 earnings reflected lower revenues and elevated operating expenses.
Legg Mason (LM) Q1 Earnings Beat Estimates, Expenses Rise
by Zacks Equity Research
Legg Mason Inc. (LM) reported positive earnings surprise of 53.5% in first-quarter fiscal 2018 (ended Jun 30).
Investment Managers' Earnings on Jul 28: BEN, VRTS & WETF
by Zacks Equity Research
Positive markets, favorable currencies and better-than-expected flows are anticipated to drive investment managers' results in the June-end quarter.
Investment Managers' Q2 Earnings on Jul 27: IVZ, PFG & FII
by Zacks Equity Research
Investment managers are likely to report decent results driven by positive markets, favorable currencies and better-than-expected flows.
3 Buy-Ranked Stocks That Just Crushed Earnings
by Jeffrey Hymen
These earnings reports not only demonstrate the past quarter???s solid performance, but they also preview its financial outlook over its next operational quarter.
T. Rowe Price's (TROW) Q2 Earnings Beat, Costs Escalate
by Zacks Equity Research
T. Rowe Price Group, Inc. (TROW) reported positive earnings surprise of 0.8% for second-quarter 2017 on higher revenues and assets under management (AUM).
T. Rowe Price (TROW) Q2 Earnings Beat on High Revenue
by Zacks Equity Research
T. Rowe Price came out with adjusted earnings per share of $1.28, beating the Zacks Consensus Estimate of $1.27. Higher revenues were primarily responsible for this earnings beat.
Will Zions (ZION) Stock Beat Q2 Earnings on Higher Rates?
by Zacks Equity Research
Zions' (ZION) Q2 earnings are expected to be supported by rising interest rates and loan growth.
Investment Managers Q2 Earnings Slated on Jul 25: AMP, TROW
by Zacks Equity Research
Improvement in AUM and low equity market volatility will support investment managers' performance in Q2 earnings.